Marc S. Ernstoff, MD, provides recommendations for managing patients with metastatic melanoma.
Marc Ernstoff, MD
Advertisement
Articles by Marc Ernstoff, MD
Marc S. Ernstoff, MD, discusses why physicians would treat metastatic melanoma with immunotherapy prior to small molecule inhibitors in most cases.
Marc S. Ernstoff, MD, discusses metastatic melanoma and how patients may be managed.
Marc Ernstoff, MD, director of melanoma, Cleveland Clinic, discusses progression-free survival (PFS) and safety in patients with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI).
Advertisement
Latest Updated Articles
PFS and Safety With Nivolumab Plus Ipilimumab in Advanced MelanomaPublished: July 17th 2015 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
